https://geneonline.news/bio-asia-taiwan-2024-regional-collaboration-forum/2024-08-14T06:14:17+00:00 https://geneonline.news/bio-asia-taiwan-2024-biosimilar-conference/2024-08-14T06:14:24+00:00 https://geneonline.news/bio-asia-taiwan-2024-digital-health/2024-08-14T06:17:31+00:00 https://geneonline.news/bio-asia-taiwan-2024-review/2024-08-14T06:17:36+00:00 https://geneonline.news/healthy-ageing-tech-show-2024-opening/2024-08-14T06:17:41+00:00 https://geneonline.news/nycu-healthy-ageing-tech-forum/2024-08-14T06:17:45+00:00 https://geneonline.news/2024-q2-financial-report-jj-abbvie-msd-roche-novartis/2024-08-19T06:31:16+00:00 https://geneonline.news/healthy-ageing-tech-show-2024-closing/2024-08-19T06:31:32+00:00 https://geneonline.news/2024-q2-financial-report-pfizer-vertex-regeneron-bms-merck/2024-08-19T06:30:46+00:00 https://geneonline.news/2024-q2-financial-report-moderna_teva_abbott_biogen_thermofisher/2024-08-19T06:30:41+00:00 https://geneonline.news/delivering-affordable-biologic-medicines-worldwide-an-interview-with-tanvex-chairman-and-ceo-henry-chen/2024-08-19T06:29:48+00:00 https://geneonline.news/2024-us-top-10-biocluster/2024-08-19T06:33:18+00:00 https://geneonline.news/2024-q2-financial-report-elililly-novonordisk-amgen-biontech-zoetis/2024-08-19T06:33:33+00:00 https://geneonline.news/novartis-receives-fda-accelerated-approval-for-fabhalta-iptacopan-the-first-and-only-complement-inhibitor-for-the-reduction-of-proteinuria-in-primary-iga-nephropathy-igan/2024-08-09T09:20:35+00:00 https://geneonline.news/serviers-1-8-billion-acquisition-pays-off-fda-approves-first-in-class-treatment-for-two-types-of-rare-brain-cancer/2024-08-09T10:11:14+00:00 https://geneonline.news/2024-q2-financial-report-bayer-gilead-illumina-beigene/2024-08-19T08:38:25+00:00 https://geneonline.news/fda-approves-first-nasal-spray-for-treatment-of-anaphylaxis/2024-08-21T08:05:04+00:00 https://geneonline.news/merck-to-acquire-investigational-b-cell-depletion-therapy-cn201-from-curon-biopharmaceutical/2024-08-19T06:34:03+00:00 https://geneonline.news/blood-test-uses-protein-clock-to-predict-risk-of-alzheimers-and-other-diseases/2024-08-19T06:34:13+00:00 https://geneonline.news/oneness-biotech-fespixon-indonesian-approval/2024-08-22T03:27:44+00:00 https://geneonline.news/formosa-pharmaceuticals-listed-on-the-taiwan-stock-exchange/2024-08-22T03:27:42+00:00 https://geneonline.news/lilly-opens-state-of-the-art-research-and-development-center-in-the-boston-seaport/2024-08-22T03:27:40+00:00 https://geneonline.news/enhertu-approved-in-china-for-patients-with-previously-treated-her2-positive-advanced-or-metastatic-gastric-cancer/2024-08-22T03:27:34+00:00 https://geneonline.news/neuronal-substance-p-drives-metastasis-through-an-extracellular-rnatlr7-axis/2024-08-28T03:21:34+00:00 https://geneonline.news/leqembi-lecanemab-approved-for-the-treatment-of-alzheimers-disease-in-the-united-arab-emirates/2024-08-28T03:22:21+00:00 https://geneonline.news/illumina-announces-strategy-to-accelerate-value-creation/2024-08-28T03:22:15+00:00 https://geneonline.news/alzheimers-disease-cellular-resilience-wtchen-interview/2026-01-26T06:06:10+00:00 https://geneonline.news/moderna-and-coursera-launch-free-course-on-mrna-technology/2024-08-15T06:09:01+00:00 https://geneonline.news/gileads-livdelzi-seladelpar-granted-accelerated-approval-for-primary-biliary-cholangitis-by-u-s-fda/2024-08-28T03:22:08+00:00 https://geneonline.news/astrazenecas-two-major-therapies-approved-in-the-us-and-europe-offering-new-opportunities-for-endometrial-cancer-and-small-cell-lung-cancer-treatments/2024-08-28T03:22:03+00:00 https://geneonline.news/fda-rejects-ecstasy-as-a-therapeutic-drug-whats-next-for-psychedelic-therapy/2024-08-28T03:21:58+00:00 https://geneonline.news/u-s-government-announces-final-prices-for-first-10-medicare-part-d-drugs-marking-completion-of-historic-drug-price-negotiations/2024-09-12T09:53:17+00:00 https://geneonline.news/incyte-and-syndax-announce-u-s-fda-approval-of-niktimvo-axatilimab-csfr-for-the-treatment-of-chronic-graft-versus-host-disease/2024-08-28T03:22:28+00:00 https://geneonline.news/taiwan-advance-bio-pharmaceutical-spinal-cord-injury/2024-08-16T07:21:40+00:00 https://geneonline.news/stli-2024-webinar2-nucleic-acid-drugs/2026-01-26T06:05:44+00:00 https://geneonline.news/fda-roundup-august-16-2024/2024-09-05T08:40:15+00:00 https://geneonline.news/2024-q2-financial-report-az-gsk/2024-09-09T06:57:13+00:00 https://geneonline.news/biotech-financing-darkest-before-the-dawn/2024-09-05T08:40:13+00:00 https://geneonline.news/2024-h2-obesity-clinical-trials/2024-09-12T09:53:19+00:00 https://geneonline.news/gsk-b7-h3-adc-us-fda-breakthrough-therapy-designation/2024-09-05T08:39:26+00:00 https://geneonline.news/astrazeneca-daiichi-sankyo-enhertu-breakthrough-therapy-designation-ema-validation/2024-09-05T08:40:04+00:00 https://geneonline.news/bora-completes-acquisition-of-us-sterile-fill-finish-facility-from-emergent/2024-09-05T08:40:02+00:00 https://geneonline.news/tirzepatide-reduced-the-risk-of-developing-type-2-diabetes-by-94-in-adults-with-pre-diabetes-and-obesity-or-overweight/2024-09-05T08:39:50+00:00 https://geneonline.news/fasenra-approved-in-china-for-the-treatment-of-severe-eosinophilic-asthma/2024-09-05T08:39:45+00:00 https://geneonline.news/otezla-apremilast-available-in-the-u-s-for-moderate-to-severe-pediatric-plaque-psoriasis/2024-09-05T08:39:45+00:00 https://geneonline.news/johnson-johnson-to-acquire-v-wave-2024/2024-09-05T08:39:48+00:00 https://geneonline.news/rybrevant-plus-lazcluze-approved-in-the-u-s-as-a-first-line-chemotherapy-free-nsclc-treatment/2024-09-09T14:18:43+00:00 https://geneonline.news/health2sync-collaborates-with-sanofi-to-expand-into-the-south-korean-market/2024-08-21T13:45:49+00:00 https://geneonline.news/artificial-intelligence-ai-accelerates-antibody-design-and-generates-data-to-assist-antibody-design-and-rapid-iterative-optimization/2024-09-09T14:18:30+00:00 https://geneonline.news/european-medicines-agency-validates-bristol-myers-squibbs-application-for-car-t-cell-therapy-breyanzi-for-relapsed-or-refractory-follicular-lymphoma/2024-08-22T07:50:02+00:00 https://geneonline.news/computer-aided-drug-discovery-revolution-challenges/2024-09-09T14:18:27+00:00 https://geneonline.news/2024-btc-smart-health-ai/2024-09-09T14:18:15+00:00 https://geneonline.news/2024-btc-created-in-taiwan-smart-technology-accelerates-cross-domain-innovation-in-biomedicine/2024-09-09T14:19:23+00:00 https://geneonline.news/2024-btc-taiwan-ai-university-alliance-standardization-convenience-and-cross-field-smart-medical-care/2024-09-09T14:18:05+00:00 https://geneonline.news/2024-btc-gene-cell-therapy-outsourcing-center/2024-09-09T14:18:07+00:00 https://geneonline.news/2024-btc-complete-the-new-drug-industry-chain-strengthen-continuous-smart-manufacturing-and-enhance-the-international-image-of-taiwans-emerging-medical-industry/2024-09-09T14:17:51+00:00 https://geneonline.news/bora-pharmaceuticals-acquires-30-5-of-tanvex-biopharma-and-becomes-the-largest-legal-shareholder/2024-08-30T08:26:22+00:00 https://geneonline.news/2024-btc-great-alliance-of-medical-materials-and-pharmaceuticals-high-level-talents-return-to-taiwan/2024-09-09T14:17:45+00:00 https://geneonline.news/2024-btc-continue-to-contribute-to-society-after-retirement-delay-aging-and-reduce-long-term-care/2024-09-09T14:17:39+00:00 https://geneonline.news/2024-btc-regulation-adjustment-and-policy-promotion-of-whole-person-health-care-infrastructure/2024-09-12T09:53:22+00:00 https://geneonline.news/2024-btc-summary/2024-09-17T03:57:43+00:00 https://geneonline.news/2024-ers-copd-dupixent-itepekimab/2024-09-12T09:17:48+00:00 https://geneonline.news/fda-roundup-august-27-2024/2024-09-12T09:17:44+00:00 https://geneonline.news/nvidia-2024-q2-financial-report/2024-09-12T09:17:42+00:00 https://geneonline.news/msd-keytruda-challenge-on-new-indication-pharma-essentia-new-competitor/2024-09-12T09:17:35+00:00 https://geneonline.news/stli-2024-webinar3-ai-ml-clinical-trials/2026-01-26T06:05:58+00:00